Biogen Idec Leverages Up For $3 Billion Share Buyback Plan (BIIB)
Biogen Idec inc. (BIIB-NASDAQ) is trading up roughly 4% pre-market at $51.40, within striking distance of its $52.72 high over the last year on news of a share buyback plan. That is also the high since its Tysabri withdrawal in…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Biogen Idec inc. (BIIB-NASDAQ) is trading up roughly 4% pre-market at $51.40, within striking distance of its $52.72 high over the last year on news of a share buyback plan. That is also the high since its Tysabri withdrawal in 2005. This is not a run of the mill buyback where the company says it will buyback shares and only purchases a few here and there. The company already had an active 20 million share buyback plan.
For starters this is a $3 Billion buyback, but it is specifying that it is roughly 57 million shares through a ‘modified Dutch tender offer.” This is more than 15% of the outstanding shares and it is good between price collars of $47.00 and $53.00.
The tender offer is subject to financing of $1.5 Billion cash and $1.5 Billion in debt issuance. Biogen has signed Merrill Lynch and Goldman Sachs for the $1.5 Billion term loan that will finance half of the tender offer. Prior to this tender, the company had over $1.1 Billion in liquidity (not including $800 million in other short term assets) and roughly $862 million in long-term debt (total liabilities $1.362 Billion).
Jon C. Ogg
May 30, 2007
Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.
Contact [email protected] for any questions or corrections.
Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.
McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.
His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.
A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.
TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.
McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.
